VRTX - Vertex Pharmaceuticals Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue2,488,6521,702,1771,032,336580,415
Cost of Revenue1,439,7441,258,1501,120,434916,493
Gross Profit1,048,908444,027-88,098-336,078
Operating Expenses
Research Development----
Selling General and Administrative496,079432,829376,575305,409
Non Recurring----
Others----
Total Operating Expenses1,935,8231,690,9791,497,0091,221,902
Operating Income or Loss552,82911,198-464,673-641,487
Income from Continuing Operations
Total Other Income/Expenses Net-568,518-78,564-93,127-93,388
Earnings Before Interest and Taxes552,82911,198-464,673-641,487
Interest Expense-57,550-81,432-84,206-72,863
Income Before Tax-15,689-67,366-557,800-734,875
Income Tax Expense-107,32416,66530,3816,958
Minority Interest13,727181,609153,66121,177
Net Income From Continuing Ops91,635-84,031-588,181-741,833
Non-recurring Events
Discontinued Operations----912
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income263,484-112,052-556,334-738,555
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares263,191-112,052-556,334-738,555